Merozyne Therapeutics (private company)

See something wrong or missing? Let us know
Offices:
Lund
Business model:
B2B
Investors:
we tracked 2 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Merozyne Therapeutics has been established to develop a treatment for MDC1A, a new drug for a rare incurable muscle disease - congenital muscular dystrophy.

Companies with similar profile to Merozyne Therapeutics:

CompanyCriteria
Sweden Monocl
46%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Almi Invest
Denmark Antag
46%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Sweden ObsteCare
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Almi Invest
  • Total raised in a similar range: < 1M USD
Sweden Inhalation Sciences
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Almi Invest
  • Total raised in a similar range: < 1M USD
Sweden MedFilm
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Almi Invest
  • Total raised in a similar range: < 1M USD
Sweden Nosa
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Almi Invest
  • Total raised in a similar range: < 1M USD
Sweden Monivent
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Almi Invest
  • Total raised in a similar range: < 1M USD
Sweden BiBB Instruments
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Almi Invest
  • Total raised in a similar range: < 1M USD
Sweden LipUm
45%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Almi Invest
  • Total raised in a similar range: < 1M USD
Sweden PressCise AB
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Almi Invest
  • Total raised in a similar range: < 1M USD
Sweden Ilya Pharma
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: < 1M USD
Sweden Aim Sweden
35%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Almi Invest
Sweden Captario
35%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Almi Invest
Sweden AMRA
35%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Denmark Acesion Pharma
35%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Denmark Reapplix
35%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Sweden Promimic
35%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Almi Invest
Sweden Bioservo Technologies
35%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Almi Invest
Denmark Biosyntia
35%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Finland Ginolis
35%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Almi Invest